This inventor holds 3 USPTO granted patents. Top assignee: Schering Corporation. Active years: 2004-2008.
Company Filing History:
Years Active: 2004-2008
Title: Tanaz Hashemi: Innovator in Mammalian Galanin Receptors
Introduction
Tanaz Hashemi is a prominent inventor based in Kenilworth, NJ (US). She has made significant contributions to the field of biomedical research, particularly in the area of mammalian galanin receptors. With a total of 3 patents to her name, Hashemi's work has the potential to impact medical treatments for conditions related to galanin.
Latest Patents
Hashemi's latest patents focus on isolated mammalian GalR3 receptors. The inventions provide isolated or recombinant nucleic acids and recombinant vectors encoding these receptors. Additionally, the patents describe host cells that comprise the nucleic acids and vectors, along with methods for producing the receptors using these host cells. Furthermore, the inventions include antibodies and antigen-binding fragments that specifically bind to the receptors, which are useful for treating medical conditions caused or mediated by galanin. The patents also outline screening methods for identifying specific agonists and antagonists of the mammalian GalR3 receptors.
Career Highlights
Tanaz Hashemi is currently employed at Schering Corporation, where she continues to advance her research in the field. Her innovative work has garnered attention and respect within the scientific community.
Collaborations
Hashemi collaborates with notable colleagues, including Marvin L Bayne and Chaogang He. These partnerships enhance her research efforts and contribute to the development of new therapeutic approaches.
Conclusion
Tanaz Hashemi is a dedicated inventor whose work on mammalian galanin receptors holds promise for future medical advancements. Her contributions to the field are noteworthy and reflect her commitment to innovation in biomedical research.